Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 10, 2016
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic studyMao-Song Tsai, Sui-Yuan Chang, Shu-Wen Lin, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 18, 2020
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppressionWei-Chieh Huang, Chun-Kai Huang, Sung-Hsi Huang, et al.Journal of the International AIDS Society|November 25, 2021
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamideBo-Huang Liou, Chih-Ning Cheng, Ya-Ting Lin, et al.Journal of Clinical Medicine|June 9, 2019
Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBIMeng-Rui Lee, Hung-Ling Huang, Shu-Wen Lin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIVSung-Hsi Huang, Wei-Chieh Huang, Shu-Wen Lin, et al.Plos One|September 12, 2015
Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyKuan-Yin Lin, Sih-Han Liao, Wen-Chun Liu, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2014
Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in TaiwanYu-Tzu Tseng, Chia-Jui Yang, Sui-Yuan Chang, et al.Plos One|September 4, 2014
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumoniaJen-Jia Yang, Chung-Hao Huang, Chun-Eng Liu, et al.Journal of the International AIDS Society|November 14, 2014
Effectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoringShang-Ping Yang, Wen-Chun Liu, Kuan-Yeh Lee, et al.Open Forum Infectious Diseases|March 9, 2026
Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in TaiwanYu-Wen Wang, Chih-Ning Cheng, Chien-Ting Lin, et al.Pageof 10